After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy? [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
The stock has been very volatile this year, with its shares trading up and down on any news related to GLP-1 weight loss drugs. So far, the news has generally been good and the stock has still climbed by more than 225% over the past year. Let's take a closer look at the telehealth company's most recent results to see if it could still be a once-in-a-decade buy. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » Hims & Hers once again delivered a blowout quarter with surging revenue. Revenue soared 77% year over year to $401.6 million, coming in well ahead of the $375 million to $380 million in revenue it forecast and the $382.2 million analyst consensus. Net orders jumped 20% to 2.66 million, while average order value (AOV) soared 48% to $147. Subscribers increased 44% year over year to 2.05 million, with 180,000 net new subscribers added in the quarter. The company said that over half its subscribers now use personalize
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss JourneysBusiness Wire
- Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead [Seeking Alpha]Seeking Alpha
- Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at TD Cowen. They now have a $28.00 price target on the stock.MarketBeat
- Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 11/4/24 - Beat
HIMS
Sec Filings
- 11/21/24 - Form 8-K
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- HIMS's page on the SEC website